A vs ONC

Agilent Technologies exhibits strong fundamental health with a Piotroski F-Score of 8/9, indicating robust accounting strength, and solid profitability metrics including an ROE of 20.62% and operating margin of 26.38%. The company is growing revenue and earnings at double-digit rates, supported by consistent earnings beat rates and strong cash flow generation, though key financial data like Altman Z-Score and cash/debt figures are missing. However, the stock trades at a premium valuation (P/E of 30.28 vs sector average of 215 but with much lower growth than peers), and insider selling activity raises caution. While analysts are bullish with a $169.67 target price, the technical trend is bearish and recent price performance has been weak over the past year despite a short-term rebound.

ONC exhibits strong operational health with a Piotroski F-Score of 7/9 and a robust balance sheet characterized by low debt (D/E 0.25) and high liquidity. However, there is a severe disconnect between the current market price ($319.94) and deterministic value metrics, with the Graham Number ($47.6) and Intrinsic Value ($17.92) suggesting massive overvaluation. While the company has successfully transitioned from deep historical losses to profitability and maintains strong revenue growth (32.8%), aggressive insider selling by the CEO and a bearish technical trend offset the 'Strong Buy' analyst consensus.